Advanced search

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

(2006) BLOOD. 107(8). p.3053-3057
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
CHOQUET, S, V LEBLOND, R HERBRECHT, G SOCIE, AM STOPPA, P VANDENBERGHE, A FISCHER, et al. 2006. “Efficacy and Safety of Rituximab in B-cell Post-transplantation Lymphoproliferative Disorders: Results of a Prospective Multicenter Phase 2 Study.” Blood 107 (8): 3053–3057.
APA
CHOQUET, S., LEBLOND, V., HERBRECHT, R., SOCIE, G., STOPPA, A., VANDENBERGHE, P., FISCHER, A., et al. (2006). Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. BLOOD, 107(8), 3053–3057.
Vancouver
1.
CHOQUET S, LEBLOND V, HERBRECHT R, SOCIE G, STOPPA A, VANDENBERGHE P, et al. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. BLOOD. AMER SOC HEMATOLOGY; 2006;107(8):3053–7.
MLA
CHOQUET, S, V LEBLOND, R HERBRECHT, et al. “Efficacy and Safety of Rituximab in B-cell Post-transplantation Lymphoproliferative Disorders: Results of a Prospective Multicenter Phase 2 Study.” BLOOD 107.8 (2006): 3053–3057. Print.
@article{345041,
  author       = {CHOQUET, S and LEBLOND, V and HERBRECHT, R and SOCIE, G and STOPPA, AM and VANDENBERGHE, P and FISCHER, A and MORSCHHAUSER, F and SALLES, G and FEREMANS, W and VILMER, E and PERALDI, MN and LANG, P and LEBRANCHU, Y and OKSENHENDLER, E and GARNIER, JL and LAMY, T and JACCARD, A and FERRANT, A and Offner, Fritz and HERMINE, O and MOREAU, A and FAFI-KREMER, S and MORAND, P and CHATENOUD, L and BERRIOT-VAROQUEAUX, N and BERGOUGNOUX, L and MILPIED, N},
  issn         = {0006-4971},
  journal      = {BLOOD},
  language     = {eng},
  number       = {8},
  pages        = {3053--3057},
  publisher    = {AMER SOC HEMATOLOGY},
  title        = {Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study},
  volume       = {107},
  year         = {2006},
}

Web of Science
Times cited: